|
Basic
loss per share is calculated based on the weighted-average number of outstanding common shares during the applicable period. Diluted
loss per share is based on the weighted-average number of outstanding common shares plus the weighted-average number of potential outstanding
common shares. In periods where they are anti-dilutive, such amounts are excluded from the calculations of dilutive loss earnings per
shares. The following table reconciles the loss and average share amounts used to compute both basic and diluted loss per share:
Schedule
of Earning Per Share
| (Amounts in Thousands, Except for Per Share Amounts) |
|
2023 |
|
|
2022 |
|
| |
|
Three Months Ended |
|
| |
|
(Unaudited) |
|
| |
|
March 31, |
|
| (Amounts in Thousands, Except for Per Share Amounts) |
|
2023 |
|
|
2022 |
|
| Loss per common share from continuing operations |
|
|
|
|
|
|
|
|
| Loss from continuing operations, net of taxes |
|
$ |
(318 |
) |
|
$ |
(1,249 |
) |
| Basic and diluted loss per share |
|
$ |
(.02 |
) |
|
$ |
(.09 |
) |
| |
|
|
|
|
|
|
|
|
| Loss per common share from discontinued operations, net of taxes |
|
|
|
|
|
|
|
|
| Loss from discontinued operations, net of taxes |
|
$ |
(93 |
) |
|
$ |
(94 |
) |
| Basic and diluted loss per share |
|
$ |
(.01 |
) |
|
$ |
(.01 |
) |
| |
|
|
|
|
|
|
|
|
| Net loss per common share |
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(411 |
) |
|
$ |
(1,343 |
) |
| Basic and diluted loss per share |
|
$ |
(.03 |
) |
|
$ |
(.10 |
) |
| |
|
|
|
|
|
|
|
|
| Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
| Basic weighted average shares outstanding |
|
|
13,358 |
|
|
|
13,234 |
|
| Add: dilutive effect of stock options |
|
|
— |
|
|
|
— |
|
| Add: dilutive effect of warrants |
|
|
— |
|
|
|
— |
|
| Diluted weighted average shares outstanding |
|
|
13,358 |
|
|
|
13,234 |
|
| |
|
|
|
|
|
|
|
|
| Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include: |
|
|
|
|
|
|
|
|
| Stock options |
|
|
335 |
|
|
|
405 |
|
| Warrant |
|
|
— |
|
|
|
— |
|
| Antidilutive Securities |
|
|
— |
|
|
|
— |
|
|